SIDRANSKY DAVID 5
5 · Orgenesis Inc. · Filed Feb 14, 2022
Insider Transaction Report
Form 5
Orgenesis Inc.ORGS
SIDRANSKY DAVID
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-12-16+2,045→ 20,450 totalExercise: $2.89From: 2022-12-16Exp: 2031-12-15→ Common Stock (20,450 underlying)
Footnotes (1)
- [F1]On December 16, 2021, the Board granted the Reporting Person options to purchase 20,450 shares at the exercise price of $2.89 per share. The options vest in full one year from the date of grant.